Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2022 Results - Earnings Call Transcript
01:13pm, Friday, 12'th Aug 2022
ImmuCell Corporation (NASDAQ:ICCC ) Q2 2022 Earnings Conference Call August 12, 2022 9:00 AM ET Company Participants Joe Diaz - Investor Relations Michael Brigham - President and Chief Executive Offic
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
10:30am, Thursday, 04'th Aug 2022 GlobeNewswire Inc.
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
06:30am, Thursday, 04'th Aug 2022
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
12:05am, Thursday, 28'th Jul 2022 GlobeNewswire Inc.
PORTLAND, Maine, July 27, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
10:30am, Thursday, 07'th Jul 2022 GlobeNewswire Inc.
PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2022 Results - Earnings Call Transcript
12:20pm, Friday, 13'th May 2022
ImmuCell Corporation (NASDAQ:ICCC ) Q1 2022 Earnings Conference Call May 13, 2022 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Joseph Crabb - Form
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
08:05pm, Thursday, 12'th May 2022 GlobeNewswire Inc.
Q1 2022 Product Sales Increased 46% over Q1 2021 Q1 2022 Product Sales Increased 46% over Q1 2021
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
10:00am, Tuesday, 10'th May 2022
Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET
UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05:18pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- Certain immaterial corrections have been made to the second and fifth paragraphs.
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
03:17pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
08:05pm, Monday, 11'th Apr 2022 GlobeNewswire Inc.
PORTLAND, Maine, April 11, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and market
A Peek Behind the Insurance Marketing Curtain
05:14pm, Friday, 11'th Mar 2022 Wealth Management
The IUL marketing insurance companies sell the agents, who in turn, sell the public, doesn’t sit well with me.
Differences Between IUL and Whole Life Insurance
08:14am, Thursday, 10'th Mar 2022 Investopedia
A look at the key differences between indexed univeral life insurance and whole life insurance and some tips for individuals trying to decide between them.
ImmuCell Corp (ICCC) CEO Michael Brigham Q4 2021 Results Earnings Call Transcript
06:49pm, Wednesday, 23'rd Feb 2022 Seeking AlphaImmuCell Corp (ICCC) CEO Michael Brigham Q4 2021 Results Earnings Call Transcript
01:49pm, Wednesday, 23'rd Feb 2022
ImmuCell Corp (ICCC) CEO Michael Brigham Q4 2021 Results Earnings Call Transcript
